First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
Clayton S. Lewis(University of Cincinnati Medical Center), Vladimir Y. Bogdanov(University of Cincinnati Medical Center)
Cited by 0
Related Papers
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner
|Proceedings of the National Academy of Sciences|2013|65